Page last updated: 2024-12-06

3,17-dihydroxy-5-estrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

3,17-dihydroxy-5-estrene: identified in urine samples from two male horses aged 8 & 14 years; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9814177
SCHEMBL ID6577330
MeSH IDM0122529

Synonyms (17)

Synonym
3,17-dihydroxy-5-estrene
19-nor-delta(sup 5(10))-androstene-3,17-diol
96744-97-7
4287v1q45g ,
unii-4287v1q45g
estr-5(10)-ene-3,17-beta-diol
4993-32-2
3beta,17beta-dihydroxy-19-norandrost-5(10)-ene
3|a,17|a-dihydroxy-19-norandrost-5(10)-ene
SCHEMBL6577330
estr-5(10)-ene-3,17-.beta.-diol
IBHQSODTBQCZDA-MACGOEAWSA-N
(3s,8r,9s,13s,14s,17s)-13-methyl-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol
Q27258513
3?,17?-dihydroxy-19-norandrost-5(10)-ene
5(10)-estren-3.beta.,17.beta.-diol
DTXSID001311177
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]